Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FWRVF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,419
Award facts
- Contract value 100% obligated
- $3,419.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, valued at $3,419.20, with a firm fixed price structure and an ultimate completion date of June 25, 2025. This non-competitive, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The award was issued on June 3, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order exemplifies the scope of AmerisourceBergen's federal pharmaceutical supply capabilities within the Defense Health Agency's medical supply chain. The company serves as a critical vendor for military and veteran healthcare systems, providing a comprehensive portfolio of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a major pharmaceutical distributor holding this substantial global pharmaceutical support vehicle, AmerisourceBergen is positioned to deliver specialized medical products such as BOTOX to support Department of Defense medical operations worldwide. The DLA Troop Support is concurrently planning next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple awards anticipated across separate regions, reflecting the strategic importance of competitive pharmaceutical procurement within federal healthcare procurement.
Quick answers
Who was awarded contract SPE2DB25FWRVF?
SPE2DB25FWRVF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 3, 2025.
How much is contract SPE2DB25FWRVF worth?
The government has obligated $3,419 on SPE2DB25FWRVF.
Is contract SPE2DB25FWRVF an order under another contract?
Yes. SPE2DB25FWRVF is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB25FWRVF competed?
The extent of competition for SPE2DB25FWRVF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award